David Peinsipp

David Peinsipp

Partner
Full contact info

I believe corporate law can be as creative and disruptive as the clients I represent.

Passions

IPOs

Literature

Gator football

Experience

Septerna Announces Upsized $331.2 Million IPO

November 1, 2024

Cooley advised the underwriters of Septerna, a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery, on its upsized $331.2 million initial public offering.

Read more

Related contacts

Denny Won
Partner, San Francisco
Charlie Kim
Partner, San Diego
Kristin VanderPas
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Claire Keast-Butler
Co-Partner in Charge – London, London
Xander Lee
Partner, Santa Monica
Barbara Mirza
Partner, Santa Monica
Phil Mitchell
Partner, New York
Dr. Madhuri Roy
Partner, Palo Alto
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Elizabeth Caruso
Associate, New York
Grady Chang
Associate, Santa Monica
Mandy Ching
Associate, London
Megan Drill
Associate, San Diego
Allison Kutner
Associate, New York
Sarah Miller
Associate, New York
Marjorie Roesser
Associate, San Francisco
Minkyu Park
Associate, New York
Dr. Mark Westwood
Associate, Palo Alto
Hardy Zhou
Associate, New York

Related Practices & Industries

Upstream Bio Announces Upsized $293 Million IPO

October 15, 2024

Cooley advised the underwriters of Upstream Bio, a clinical-stage biotech developing a monoclonal antibody to target respiratory disorders, on its upsized $293 million initial public offering.

Read more

Related contacts

Kristin VanderPas
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Denny Won
Partner, San Francisco
Charlie Kim
Partner, San Diego
Claire Keast-Butler
Co-Partner in Charge – London, London
Xander Lee
Partner, Santa Monica
Barbara Mirza
Partner, Santa Monica
Phil Mitchell
Partner, New York
Dr. Madhuri Roy
Partner, Palo Alto
Francis Wheeler
Partner, Colorado
Rebecca Ross
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Elizabeth Caruso
Associate, New York
Mandy Ching
Associate, London
Megan Drill
Associate, San Diego
Zack Gong
Associate, Shanghai
Peter A. Haddad
Associate, San Diego
David D. Kim
Associate, San Francisco
Jessica Koffel
Associate, Brussels
Sarah Miller
Associate, New York
Lawrence Traylor
Associate, Santa Monica

Related Practices & Industries

Cooley Advises Uber on $5 Billion Investment-Grade Revolving Credit Facility

October 2, 2024

Cooley advised Uber Technologies on its $5 billion investment-grade revolving credit facility.

Read more

Related contacts

Mischi a Marca
Partner, San Francisco
Matt Kong
Associate, San Francisco
Xueqing Li
Associate, San Francisco
Jason Savich
Partner, San Francisco
Ellie Seber
Partner, Santa Monica
Addison Pierce
Associate, Chicago
Natasha Kaye
Partner, London
Eileen Marshall
Partner, Washington, DC
David Peinsipp
Partner, San Francisco
Timothy Shapiro
Partner, Palo Alto
David Wilson
Partner, London
Francis Wheeler
Partner, Colorado
Stacey A. Bradford
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Siana Lowrey
Of Counsel
Arielle H. Friehling
Associate, San Francisco
Yichao Zhang
Associate, New York
Jennifer Fitzpatrick
Paralegal Specialist, Washington, DC
Chris Rhem
Paralegal Specialist, San Francisco

Related Practices & Industries

BioAge Labs Announces $198 Million IPO

September 27, 2024

Cooley advised the underwriters of BioAge Labs, a clinical-stage biotechnology company that is harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases, on its $198 million initial public offering.

Read more

Related contacts

Charlie Kim
Partner, San Diego
Denny Won
Partner, San Francisco
Div Gupta
Partner, New York
Dr. Jon Cousin
Partner, Washington, DC
Lila Hope
Partner, Palo Alto
Xander Lee
Partner, Santa Monica
Joshua Mates
Partner, San Francisco
Phil Mitchell
Partner, New York
Alessandra Murata
Partner, Palo Alto
David Peinsipp
Partner, San Francisco
Dr. Madhuri Roy
Partner, Palo Alto
Francis Wheeler
Partner, Colorado
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Elizabeth Caruso
Associate, New York
Tony P. Guan
Associate, Santa Monica
Tony P. Guan
Associate, Santa Monica
Jonathan Kaufman
Associate, Palo Alto
Wyatt Kernell
Associate, Colorado
Ryan Lewis
Associate, Colorado
Sarah Miller
Associate, New York
Dr. Eric Owens
Associate, New York
Breanna Qin
Associate, Palo Alto
Dr. Xixi Sun
Associate, Boston
Christine Turner
Associate, Colorado
Dr. Mark Westwood
Associate, Palo Alto
Joanna Zhang
Associate, San Diego
Daniel Manson
Patent Agent, New York
Robin K. Lee
Paralegal Specialist, Colorado

Related Practices & Industries

Zenas BioPharma Announces $225 Million IPO

September 16, 2024

Cooley advised Morgan Stanley, Jefferies, Citigroup and Guggenheim Securities as the underwriters of Zenas BioPharma’s $225 million initial public offering.

Read more

Related contacts

Richard Segal
Partner, New York
Denny Won
Partner, San Francisco
Div Gupta
Partner, New York
Evan Leitner
Associate, New York
Barbara Mirza
Partner, Santa Monica
Phil Mitchell
Partner, New York
Stephanie Gentile
Partner, New York
Austin Holt
Partner, Santa Monica
David Peinsipp
Partner, San Francisco
Dr. Madhuri Roy
Partner, Palo Alto
Geoffrey Spolyar
Partner, Boston
Francis Wheeler
Partner, Colorado
Rebecca Ross
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Nathaniel Hearn Jr.
Associate, Chicago
Wyatt Kernell
Associate, Colorado
Allison Kutner
Associate, New York
Aaron Level
Associate, New York
Brenna McGuire
Associate, New York
Amanda Pacheco
Associate, Palo Alto
Jesse Schulman
Associate, Colorado
Nitasha Bennett
Patent Agent, San Diego
Jeffery Wyzykowski
Patent Agent, Washington, DC

Related Practices & Industries

View more

David always has creative solutions for the more complex and bespoke issues. He has a reputation for being the go-to for answers to the hardest questions.

Chambers USA (2024)

David has a superior presence in capital markets. He is amazing in the boardroom.

Chambers USA (2024)

Admissions and credentials

California

Not admitted to practice in Florida

Rankings and accolades

Chambers USA: Band 1: Capital Markets: Debt & Equity: Western United States – Nationwide (2024)

Chambers USA: Band 1: Capital Markets: Debt & Equity – California (2024)

Chambers USA: SPACs – Nationwide (2023)

The Legal 500 US: Leading Lawyer in Capital Markets: Equity Offerings (2020 – 2023)

Daily Journal: California Lawyer Attorneys of the Year Awards (2020)

IFLR1000 US: Lawyer of the Year – Capital Markets (2020)

Daily Journal: Top 100 Lawyers in California (2019 – 2020)

Law 360: Capital Markets MVP (2019)

The Legal 500 US: Next Generation Lawyer in Capital Markets: Equity (2019)

Daily Journal: Top 20 Under 40 (2014)

Memberships and affiliations

American Bar Association (ABA)

The Bar Association of San Francisco

Representative issuers:

Dave has represented companies/investment banks on capital market transactions involving issuers across industries, such as: 10X Genomics, 4D Molecular Therapeutics, Accelerate Diagnostics, Acutus Medical, Aerohive Networks, Alteryx, ALX Oncology, Ambarella, Amyris, Applied Molecular Transport, Anthera Pharmaceuticals, Apigee, Applied Molecular Transport, Annexon, Apptio, Arcadia Biosciences, Arcutis Biotherapeutics, Aridis Pharmaceuticals, ARMO BioSciences, Ascendis Pharma, ASLAN Pharmaceuticals, Atlassian, Athira Pharma, Audentes Therapeutics, Cision, Crinetics Pharmaceuticals, Dermira, DocuSign, Doximity, Dutch Bros., EHang, Eidos Therapeutics, Expensify, Fantex, FIGS, FireEye, Five Prime Therapeutics, Global Blood Therapeutics, Gossamer Bio, Graphite Bio, Gritstone Oncology, Guardant Health, Health Catalyst, HealthEquity, Hyperion Therapeutics, IGM Biosciences, Ignyta, Immune Design, Inhibrx, Invitae, Kinnate Biopharma, Kodiak Sciences, LinkedIn, Livongo Health, Lulu’s Fashion Lounge, Lyell Immunopharma, MINDBODY, Mobile Iron, NantKwest, Nanthealth, NerdWallet, New Relic, Olema Pharmaceuticals, Ooma, Opendoor Labs, Otonomy, Pliant Therapeutics, Principia Biopharma, PROCEPT BioRobotics, ProNai, ProQR Therapeutics, PROS Holdings, Rigel Pharmaceuticals, Qualtrics, Root, Sana Biotechnology, Satsuma Pharmaceuticals, Savara, Shockwave Medical, Sierra Oncology, Smart Share Global, Snap, Stitch Fix, Sutro Biopharma, Sweetgreen, Syndax Pharmaceuticals, Tableau Software, Taiwan Liposome Company, Treace Medical Concepts, Tricida, Trivascular, Twilio, Uber, Ventyx, ViewRay, Warby Parker, Wish, Xenon Pharmaceuticals, Xometry, Yelp, Zendesk, Zscaler, Zymeworks, Zynga.